Schuler Jack W's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Apr 4, 2022
- Accession no.
- 0000899243-22-013373
- Filed
- Apr 4, 2022, 4:59 PM ET
- Trade date
- Jul 27, 2021-Mar 31, 2022
- Filing delay
- 251 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $146.3K. It was filed 251 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schuler Jack WCIK 0001021412 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | Common Stock | SSaleDisposed | −19,748 | $0.8646 | −$17,074.12 | 4,065,044 | Indirect | |
| Aug 17, 2021 | Common Stock | SSaleDisposed | −49,841 | $0.7849 | −$39,120.2 | 4,015,203 | Indirect | |
| Sep 22, 2021 | Common Stock | SSaleDisposed | −2,599 | $0.8735 | −$2,270.23 | 4,012,604 | Indirect | |
| Sep 23, 2021 | Common Stock | SSaleDisposed | −100,000 | $0.876 | −$87,600 | 3,912,604 | Indirect | |
| Feb 10, 2022 | Common Stock | SSaleDisposed | −800 | $0.3548 | −$283.84 | 3,911,804 | Indirect | |
| Mar 31, 2022 | Common Stock | PPurchaseAcquired | +4,000,000 | –F2 | – | 7,911,804 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | Common Stock | PPurchaseAcquired | +4,000,000 | –F2 | – | 4,000,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each share of common stock was purchased together with one (1) warrant to purchase one (1) share of common stock for an aggregate price of $0.25.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.
Remarks
800 of the shares purchased on March 31, 2022 are matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with certain prior sales of shares by the Schuler Education Foundation. The Schuler Education Foundation has disgorged to the Issuer, on a voluntary basis, the full amount of any recoverable profits.